Soclenicant clinical trials
Also written BNC210.
How each study uses soclenicant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2016 (1)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Bionomics Limited (5)
Studies
Open first, then newest update. How each study uses soclenicant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Efficacy of BNC210 in Acute, As-needed Treatment of Anxiety in Social Anxiety Disorder - 1CompletedPhase 3Bionomics LimitedNCT06510504Written as 225 mg BNC210
- A Phase 2 Study of BNC210 for the Acute Treatment of Social Anxiety DisorderCompletedPhase 2Bionomics LimitedNCT05193409Written as 225 mg BNC210
- A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)CompletedPhase 2Bionomics LimitedNCT04951076Written as BNC210
- Phase II Study of BNC210 in PTSDCompletedPhase 2Bionomics LimitedNCT02933606Written as BNC210
- A Study of BNC210 in Elderly Patients With AgitationCompletedPhase 2Bionomics LimitedNCT03548194Written as BNC210
Codes
What other systems call soclenicant · ClinicalTrials.gg INT017698
- UNII (FDA) QP49AY37OYSOCLENICANTConfirmed FDA, Wikidata
- Wikidata Q137901062soclenicantConfirmed FDA, Wikidata
- NCI Thesaurus C215255SoclenicantOne source FDA
- DrugBank DB19048One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | QP49AY37OY | SOCLENICANT | Confirmed FDA, Wikidata |
| Wikidata | Q137901062 | soclenicant | Confirmed FDA, Wikidata |
| NCI Thesaurus | C215255 | Soclenicant | One source FDA |
| DrugBank | DB19048 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.